医学
彭布罗利珠单抗
佐剂
肾细胞癌
肾切除术
辅助治疗
肿瘤科
内科学
癌
泌尿科
免疫疗法
肾
癌症
作者
Toni K. Choueiri,Piotr Tomczak,Se Hoon Park,Balaji Venugopal,Thomas Ferguson,Yen‐Hwa Chang,Jaroslav Hájek,Stefan N. Symeonides,Jae‐Lyun Lee,Naveed Sarwar,Antoine Thiery-Vuillemin,Marine Gross‐Goupil,Mauricio Mahave,Naomi B. Haas,Piotr Sawrycki,Howard Gurney,Christine Chevreau,Bohuslav Melichar,Evgeniy Kopyltsov,Ajjai Alva
标识
DOI:10.1056/nejmoa2106391
摘要
Patients with renal-cell carcinoma who undergo nephrectomy have no options for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI